Home Physical Sciences Identification of a novel drug target in Porphyromonas gingivalis by a computational genome analysis approach
Article Open Access

Identification of a novel drug target in Porphyromonas gingivalis by a computational genome analysis approach

  • Abdulmajeed Alqurashi , Waqar Ahmad , Ziaur Rahman EMAIL logo , Javed Nawab , Muhammad Faisal Siddiqui , Ali Akbar , Ayman Ahmad Alkraiem and Muhammad Latif EMAIL logo
Published/Copyright: June 13, 2024

Abstract

This study applied a subtractive genomics approach to identify a potential drug target in the Porphyromonas gingivalis strain (ATCC BAA-308/W83). The aim was to characterize the whole proteome and hypothetical proteins (HPs) through structural, functional, and pathway predictions. The proteome was systematically reduced to identify essential proteins (EPs), non-homologous proteins (NHPs), and non-paralogous proteins (NPPs) while excluding those that were similar to the human proteome. Out of 1,836 proteins, the cluster database at high identity with tolerance algorithm identified 36 sequences as paralogous, having 80% identity. The resulting 1,827 proteins were compared to the human proteome using BLASTp (e-value 10−3), resulting in 1,427 NHPs. These were then aligned with the DEG database using BLASTp (e-value of 10−5), identifying 396 NHPs essential for pathogen survival. CELLO predicted the sub-cellular localization, and KEGG Automated Annotation Server identified potential metabolic pathways using a BLASTp similarity search of NHPs and EPs against the infrequently updated KEGG database. A total of 79 HPs essential for P. gingivalis were selected, and their molecular weights were determined. HPs were screened for metabolic pathway prediction, and the 3D structures of the proposed HPs were determined using homology modeling, and validation was performed. Only one HP (putative arginine deiminase) was qualified and found to be involved in the arginine and proline metabolic pathway.

1 Introduction

Porphyromonas gingivalis is a Gram-negative anaerobic bacterium that causes black pigmentation in billions of individuals worldwide. The bacterium is asaccharolytic in nature, extremely proteolytic, and is frequently discovered in deep periodontal pockets in humans [1]. P. gingivalis has been reported to be an etiological substance in the pathogenesis of periodontal disease, which leads to inflammatory events [2]. The subgingival plaque samples from patients revealed 88% involvement of this bacterium in chronic periodontitis [3]. P. gingivalis has also been found to be involved in many systemic diseases [4,5]. Infection caused by various strains of P. gingivalis has revealed that the bacterium is one of the causes of triggering varying degrees of cardiac disorders. The most frequent syndromes include endothelial dysfunction, proliferation of vascular smooth muscles, aortic aneurysms, and atherosclerosis [6,7,8,9,10,11]. Several antibiotics including Minocin, tetracycline HCl, and doxycycline are usually employed in the treatment of periodontal diseases. P. gingivalis is resistant to several of the known antibiotics. Rams et al. showed that P. gingivalis resistance to amoxicillin has increased (from 0.1 to 2.8%), whereas resistance to clindamycin was low in 1999 but has increased to 9.3% by 2020 in periodontitis patients [12]. This bacterium contributes to the development of drug resistance in periodontal disease and is associated with periodontitis. The acquired resistance in patients is often anticipated by the excessive intake of antibiotics and self-medications, and not taking a proper dose at the proper time. Resistance in microorganisms causes treatment challenges in the community and poses health risks [13,14]. To overcome this challenge, there is an unmet need to investigate the genome and proteome of resistant organisms to identify novel drug targets. The discovery of new drugs against pathogens is time-consuming, tedious, and expensive and also associated with a high degree of uncertainty in terms of success rate. The use of in silico tools and highly sensitive genome sequencing are well-established alternative approaches to speed up the drug discovery process. Several bioinformatics tools are usually employed to explore the wide-ranging proteomic data obtained from microbial pathogens. In this regard, the use of subtractive genomic methodology has shown excellent potential for the prediction of possible drug targets in several virulent pathogens [15,16,17]. To date, a total of 19 genome sequences of P. gingivalis have been reported including 8 with complete sequences (strains W83, ATCC 33277, TDC60, HG66, A7436, AJW4, 381, and A7A1-28), and 11 high-coverage draft sequences (JCVI SC001, F0185, F0566, F0568, F0569, F0570, SJD2, W4087, W50, Ando, and MP4504). These sequences have been compiled into fewer than 300 contigs, but ∼60–80% of these genes can be anticipated for their potential function with sufficient reliability. The rest of the genes are either hypothetical, well-conserved hypothetical, uncharacterized, or unexplored [18]. The hypothetical proteins (HPs) are those entities that are encoded by an established open-reading frame, but due to the lack of experimental evidence, their function has not yet been confirmed. The purpose of this investigation was to identify and characterize HPs and putative drug targets among the available pool of HPs in the P. gingivalis strain by employing in silico subtractive genome analysis. To conduct this study, a previously sequenced genome (strain ATCC BAA-308/W83) was used to identify novel drug targets in the HPs with higher accuracy by employing well-optimized bioinformatics tools. The HPs were also analyzed using 3D structural prediction methods. To the best of our understanding, this study is the first report on strain (ATCC BAA-308/W83) using computational approaches to explore and provide an avenue to identify potential novel drug targets in P. gingivalis, a known causative agent of periodontal disease in humans.

2 Materials and methods

2.1 Sequence retrieval

The complete genomic strain of P. gingivalis (ATCC BAA-308/W83) comprising 1,863 protein sequences was retrieved from the NCBI database [19]. A schematic description of the workflow with the number of permissible genes at an individual screening phase is shown in Figure 1. The proteome of Homo sapiens was downloaded from the well-known UniProt database [20]. The UniProt database is among the world’s most extensively annotated protein sequence databanks comprising over one million proteins [21]. The UniProt IDs with their locations and the resulting number of retrieved sequences for P. gingivalis at each step are shown in Table 1.

Figure 1 
                  Schematic description of a workflow and the outcome of an individual step involved in computational subtractive genomics-based target identification in P. gingivalis.
Figure 1

Schematic description of a workflow and the outcome of an individual step involved in computational subtractive genomics-based target identification in P. gingivalis.

Table 1

Steps of subtractive genomic with resulting number of retrieved sequences

Sr. No. Description of step Retrieved sequences P. gingivalis
1 Total counts of proteins in the genome 1,863
2 Eliminated paralogous (>80% identical) in CD-HIT 1,827
3 Obtained proteins against H. sapiens using BLASTp (e-value 10−3) 1,427
4 EPs in DEGG (e-value 10−5) 396
5 HPs (essential, non-homologous, non-paralogue) 79
6 Functional prediction of HPs 75
7 HPs involve in metabolic pathway 01

2.2 Elimination of paralogous sequences

A cluster database at high identity with tolerance (CD-HIT) was used to identify paralogous (duplicate protein) sequences that precisely clustered the proteins based on sequence identity. By applying the CD-HIT algorithm at 80% identity, the CD-HIT categorized the sequences in descending order. This operation generated the longest sequence of a representative of the first and foremost clusters. The rest of the sequences were compared with the resulting representatives of all clusters obtained by applying the CD-HIT (http://cd-hit.org). A sequence identity of 80% was chosen as a threshold value during the analysis. For a comparison purpose of every sequence, a short word filter was applied to the sequences to establish whether the resemblance was lower than the clustering threshold [22]. The total proteins of the subjected proteome were clustered and proteins with 80% identical were scrutinized to be paralogous.

2.3 Retrieving NHP sequences

The non-paralogous sequences (non-PS) obtained from the above operation were analyzed using BLASTp against the protein group of H. sapiens by applying a threshold expectation value (e-value) of 0.001. The sequence obtained through this operation comprised homologous sequences (HS) and non-HS (no hits were observed). Notably, the HS had a considerable resemblance (similarity) to the human host. The sequences that exhibited significant resemblance to the human host were eliminated, and the non-HS were subjected to further analysis [23].

2.4 Recognition of non-homologous essential genes

The Database of Essential Genes (DEG) is a source for predicting essential genes on the basis of homologous sequence searches [24]. DEG 6.8 was downloaded from the DEG official website (http://www.essentialgene.org/). Homology with sequences present in the DEG database provides a basis for the existence of non-homologous proteins (NHPs). To do this, the NHP sequences of the ATCC BAA-308/W83 were submitted to BLASTp against DEG with an e-value of 0.00001. The sequences retrieved from this approach included all potential NHPs (1,827) and non-homologous essential proteins (EPs) (396), which are essential genes for P. gingivalis but found in the host. These identified sequences were determined as essential and viable for the survival of the pathogen.

2.5 Selection of HPs

The HPs are those proteins whose functions are not known and are translated by an open-reading frame of the genome. A total of 79 HPs that were non-homologous, non-paralogous, and essential for P. gingivalis were selected from known functional proteins for further studies.

2.6 Sub-cellular localization prediction

The CELLO has been reported to be a useful tool for predicting sub-cellular localizations of the proteins present in proteomic data sets. The CELLO predicts the sub-cellular localizations of a query protein using an updated and well-trained model. The CELLO predicts four sub-cellular localizations in Gram-positive bacteria and five in Gram-negative bacteria [25]. A study demonstrated that cytoplasmic proteins are the most frequent drug targets [26]; however, membrane proteins are vaccine targets [27]. Using the CELLO v.2.5., we subjected the non-homologous genes, non-paralogous genes, and essential genes of P. gingivalis to prognosticate the sub-cellular localization.

2.7 Functional and family prediction of all NHPs

Support vector machine (SVM-Prot) is another web-based server applied for the categorization of proteins into functional families using the primary sequences [28]. SVM-Prot has a precise degree of capability to classify the distantly linked proteins and HPs of different functions and is applied as a tool for predicting protein functions. The non-PS, non-homologous sequences, and essential sequences of P. gingivalis were added to the online server of SVM-Prot to predict their functional family classification.

2.8 Proteins molecular weight

The Protein Molecular Weight database accepts the protein sequence and calculates their molecular weight. In this study, all the HPs were submitted to the Protein Molecular Weight database to evaluate their molecular weight.

2.9 Metabolic pathway analysis

The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a popular tool for systematic screening of functions of a gene and associating genomic data with a higher level of functional annotations [27,29]. To identify potential metabolic pathways using KEGG, the widely used server KAAS (KEGG Automated Annotation Server) was used to perform a BLASTp similarity search of NHPs and EPs against the infrequently updated KEGG database [30]. Moreover, the KAAS not only provides key information related to the metabolic pathways but also suggests distinguishing features of the information that comprise KEGG Ontology (KO) designation lists. Moreover, information regarding the alternative pathways along with the corresponding enzymes and enzyme commission numbers can also be obtained via KASS. In the initial step, the BLAST score was computed between the request sequence and the standard sequence set. The reference or standard sequence was obtained from the KEGG GENE database. This process was used for the identification of homologs from the available reference set. In the second step, homologs ranked higher than the threshold level were carefully chosen as ortholog candidates. The selection was performed in accordance with the obtained BLAST score followed by bi-directional hit rate. Third, the potential ortholog contenders were distributed into various KO groupings corresponding to the annotations of the KEGG GENES database. In the last step, the level of assignment score was computed using probability and heuristics. The obtained results supported the prediction of possible metabolic pathways for potential drug targets.

2.10 Homology modeling

The HPs involved in the metabolic pathway and recognizable as possible targets for druggability were examined for existing crystal structures using BLAST and compared to the Protein Data Bank (PDB) database [31,32]. If the crystal structure was unavailable, then the protein sequence was used in homology modeling with the SWISS-MODEL [33]. The prototype structure was determined through the alignment of sequence compared to the available crystal structures in the PDB database. The prototype of the query protein (UniProt ID: Q7MXM8) was discovered as a crystal structure of putative arginine deaminase (PDB ID: 1ZBR. A). The SWISS-MODEL generated a modeled structure for protein and from this only one was carefully chosen. The obtained modeled structure was verified for its stereochemical quality using PROCHECK [34], VERIFY3D [35], and ERRAT servers [36].

2.11 Identification of domains and motifs

The biological functions and crucial roles of proteins are highly related to the domains and motifs of a given protein sequence. These motifs remain the main structural features that are well-conserved in the group of diverse types of proteins. Generally, proteins contain either single or more domains that act as crucial facilitators for protein functions [37]. The domain component is a functional and structural part of eukaryotic proteins that offers recommendations for the annotation of new proteins [38]. Examination of domain and motif of essential and druggable HP sequences was conducted using online tools of bioinformatics such as (i) Simple Modular Architecture Research Tool (SMART) [39], (ii) GenomeNet Motif search, and (iii) ScanProsite [40]. SMART is equipped with an end-user interface (http://www.bork.embl-heidelberg.de/Modules/sinput.shtml) to furnish a fast and automated annotation of the signaling domain arrangement of the sequence of the query protein. The outcome is described by a graphical display that shows the domain positions in a query sequence. Consequently, the resulting SMART sets of various signaling domains are meticulously annotated through hyperlinks to Medline and the Molecular Modeling Database, which can be easily accessed through Entrez [41]. This operation generated easy access to the information correlated with a sequence, homology, composition, and function.

3 Results and discussion

This study aimed to functionally characterize HPs and discover putative drug targets in P. gingivalis strain (ATCC BAA-308/W83). The putative drug targets were carefully screened by taking into consideration the drug-target-like benchmarks that demonstrated that they must be non-homologous to the host and crucial to the existence of bacteria while displaying participation in essential metabolic pathways of the bacteria. To this end, the two most important criteria for recommending a potential pharmacological target were that it be vital to the pathogen but not identical to the human host. There has been no experimental analysis to characterize the HPs present in P. gingivalis strain (ATCC BAA-308/W83) sequenced previously; hence, an effort was made to annotate the function of these HPs using an in silico approach. To describe and develop a relationship, a phylogenetic analysis of hypothetical proteins of P. gingivalis was constructed (Figure S1). With the purpose of identifying a potential drug target in P. gingivalis strain (ATCC BAA-308/W83), a computational subtractive genomics approach was applied that is a well-accepted and acknowledged approach used for the recognition and prioritization of diverse types of targets for druggability against many pathogens [42,43,44,45]. The complete workflow of this study is shown in Figure 1, and the resulting number of possible sequences at every step is shown in Table 1.

3.1 Identification of EPs, NHPs, and non-paralogous proteins (NPPs)

The full proteome of P. gingivalis strain (ATCC BAA-308/W83) was retrieved from the NCBI database. The examination of the downloaded proteome of P. gingivalis was found to comprise 1,863 proteins. The CD-HIT is a useful tool [46] that is widely employed to cluster the nucleotide or protein sequences, thereby reducing redundancy and manual efforts and enhancing the performance of other sequence analyses. After implementing the CD-HIT algorithm with an identity threshold of 80% (the used criterion), a total of 36 sequences were discovered as paralogous among the 1,836 proteins in the selected strain. It was noted that CD-HIT generated clustered the paralogous protein sequences consequently reducing the total number of sequences in the strain. The resulting 1,827 non-PS of proteome were further subjected to BLASTp (e-value 10−3) against the human proteome (H. sapiens database) to remove the HS to humans. The output provided 1,427 NHPs.

3.2 Determination of essential genes

The genes that are considered essential for a sustainable life cycle of certain bacterium are known as essential genes. The DEG comprised a comprehensive listing of bacterial genes with a complete information on corresponding sequences that are indispensable for the existence of bacterial lifecycle [47]. Using DEG analysis, we aimed to identify the essential sequences of the bacterial pathogen in P. gingivalis but not present in the host organism. A total of 1,427 NHPs were compared to the DEG databank using the BLASTp by keeping the e-value of 10−5. The outcome of this operation generated a total of 396 NHPs essential for the survival of pathogens which could have hypothetical or uncharacterized proteins. This approach conveniently screened the essential and HPs of the pathogen for subsequent analysis.

3.3 Sub-cellular localization prediction

Identifying the location of EPs is a crucial element in determining the important function of proteins in their specific cellular compartments. Recognizing the localization of a potential drug target is crucial in order to adjust the drug’s mode of action towards the target. The CELLO has been reported to be a useful tool for the prognostication of sub-cellular localization of the proteins found in proteomic data. CELLO was used to categorize drug targets into three types: the membrane, cellular, and surface proteins [48]. Figure 2 shows the localization of 75 common drug targets in this study. The findings demonstrated that out of 75 HPs, 50 drug targets were resided in cytoplasmic (67%), 11 distributed in the outer membrane (15%), 9 found in the inner membrane (12%), 1 existed in the extracellular (1%), and 4 were found in the periplasmic proteins (5%).

Figure 2 
                  Schematic representation of sub-cellular localization of non-homologous EPs of P. gingivalis strain (ATCC BAA-308/W83).
Figure 2

Schematic representation of sub-cellular localization of non-homologous EPs of P. gingivalis strain (ATCC BAA-308/W83).

3.4 Functional identification of shortlisted HPs

The understanding of protein function is a key parameter for investigating the biological phenomenon, disease mechanistic pathways, and discovering therapeutic targets [49]. Numerous bioinformatic tools have been used to characterize the HPs into their functional classes from many species. One such tool is SVMprot, which functionally classifies HPs to envision their functions on the basis of similarity and has shown good predictive performance. In this study, a total of 79 HPs were submitted to SVMprot. Only 4 sequences were found to fail because of their short amino acid length and the remaining 75 HPs were classified into several functional families containing transporters, zinc-binding proteins, and enzymes. We assigned the functional annotation to the proteins with strong confidence and concluded with the function of 75 HPs with high confidence. The outcome obtained from SVMport is presented in Table 2.

Table 2

Uniprot IDs with their potential locations

Cytoplasmic Cytoplasmic Cytoplasmic Inner membrane Outer membrane Extracellular Periplasmic
Q7MX20 Q7MW96 Q7MVV5 Q7MUT8 Q7MWV2 Q7MTZ1 Q7MT93
Q7MT62 Q7MXF2 Q7MVP6 Q7MW64 Q7MXN2 Q7MW66
Q7MVU6 Q7MWQ5 Q7MWS6 Q7MX12 Q7MXX1 Q7MXM5
Q7MX14 Q7MW58 Q7MXC7 Q7MT47 Q7MUS9 Q7MWE1
Q7MTY0 Q7MV76 Q7MV28 Q7MUH7 QTMXE2
Q7MXB9 Q7MW57 Q7MUW0 Q7MXN6 Q7MWS4
Q7MUC7 Q7M789 Q7MU54 Q7MVV6 Q7MSY4
Q7MXV1 Q7MU05 Q7MTV7 Q7MX69 Q7MWK8
Q7MTP4 Q7MXF9 Q7MWA4 Q7MTKB Q7MVL8
Q7MTQ1 Q7MTH1 Q7MXM8 Q7MXB5
Q7MTH0 Q7MT58 Q7MW65 Q7MTU1
Q7MW19 Q7MW18 Q7MUL4
Q7MVS8 Q7MUX5 Q7MVZ8
Q7MWX9 Q7MT29 Q7MX05
Q7MV71 Q7MVB2 Q7MV50
Q7MWM9 Q7MUE7 Q7MWW5
Q7MVH1 Q7MVB9

3.5 Metabolic pathway analysis

The KEGG database is a useful platform that furnishes a network of metabolic pathways along with their complete annotations. KEGG facilitates the screening of protein sequences that are necessary for serving a distinctive role in the process of metabolism. The metabolic pathway evaluation predicts a potential drug target on the basis of the pathogen’s unique metabolism. Uddin et al. identified preferred drug targets in a Mycobacterium avium [50], we followed similar protocols and focused on the identification of crucial, hypothetical, and non-HS involved in the pathways of metabolism of the P. ‎gingivalis strain using the KEGG database [51]. The KAAS utilized BLASTp for the assessment of proteins of interest against the KEGG databank and then annotated the associated potential role of the proteins. The obtained SVMprot results were subjected to the KEGG database analysis via the KAAS server. A total of 75 sequences of proteins of the P. gingivalis strain were screened via the KAAS server. As a result, out of 75 proteins, only one protein was passed by the KAAS and was discovered to be participate in the arginine and proline metabolic pathway (protein sequence with Id Q7MXM8 with KAAS server Ids: KO01100 metabolic pathways, KO00330). The distribution of HPs Uniprot IDs with their predicted function and molecular weight involved in different metabolic pathways is shown in Table 3.

Table 3

HPs Uniprot IDs with their predicted function and molecular weight

Sr. No. Uniprot IDs Predicted function Molecular weight (kDa)
1 Q7MWW5 ATP-binding cassete family 10.11
2 Q7MX20 Transporter 11.91
3 Q7MT62 Enzyme 10.09
4 Q7MTK8 Transporter 48.9
5 Q7MUT8 Transporter 19.51
6 Q7MWE1 Transporter 11.32
7 Q7MWV2 DNA replication 37.54
8 Q7MW64 Transporter 17.17
9 Q7MXI2 ATP-binding cassette family 28.21
10 Q7MVU6 Transporter 27.41
12 Q7MX14 mRNA slicing 13.52
13 Q7MTY0 Lipid binding 7.64
14 Q7MXB9 Metal binding protein 10.01
15 Q7MT47 Transporter 123.36
16 Q7MT93 mRNA slicing 15.75
17 Q7MUC7 Enzyme 14.36
18 Q7MX25 ATP-binding cassette family 11.1
19 Q7MXV1 Transporter 64.01
20 Q7MTP4 ATP-binding cassette family 74.43
21 Q7MTQ1 Lipo protein 27.57
22 Q7MXN2 Transporter 26.25
23 Q7MTH0 ATP-binding cassette family 8.5
24 Q7MWI9 Transporter 20.87
25 Q7MVS8 Lipid binding protein 12.76
26 Q7MUH7 Metal binding 10.97
27 Q7MWX9 Metal binding 27.08
28 Q7MXX1 Transporter 43.27
29 Q7MV71 DNA repair 11.86
30 Q7MWM9 DNA repair 18.11
31 Q7MXN6 ATP-binding cassette family 39.33
32 Q7MVH1 Lipid binding protein 22.2
33 Q7MVV5 Transporter 15.61
34 Q7MWS6 DNA repair 34.42
35 Q7MUS9 Transporter 108.05
36 Q7MXE2 DNA repair 53.51
37 Q7MXC7 Enzyme 46.38
38 Q7MWS4 DNA replication 58.53
39 Q7MV28 DNA repair 47.44
40 Q7MUW0 Enzyme 23.67
41 Q7MW66 DNA repair 18.1
42 Q7MU54 ATP-binding cassette family 14.75
43 Q7MTV7 ATP-binding cassette family 6.09
44 Q7MXM5 DNA repair 20.19
45 Q7MSY4 Transporter 82.84
46 Q7MWK8 Enzyme 129.26
47 Q7MTZ1 Enzyme 32.33
48 Q7MWA4 Lipid binding protein 8.27
49 Q7MW96 ATP-binding cassette family 11.09
50 Q7MXF2 ATP-binding cassette family 18.44
51 Q7MWQ5 Zinc binding 11.36
52 Q7MVL8 Enzyme 54.95
53 Q7MVV6 Transporter 8.23
54 Q7MW58 rRNA binding protein 8.82
55 Q7MV76 Lipid metabolism 47.08
56 Q7MW57 Transporter 100.68
57 Q7M789 ATP-binding cassette family 6.09
58 Q7MU05 Enzyme 24.6
59 Q7MXF9 Transporter 48.36
60 Q7MTH1 DNA replication 55.99
61 Q7MT58 DNA repair 16.65
62 Q7MXB5 Transporter 56.55
63 Q7MUX5 ATP-binding cassette family 15.36
64 Q7MX69 Transporter 21.94
65 Q7MVB2 DNA condensation 132.15
66 Q7MUE7 Transporter 36.16
67 Q7MVP6 Transporter 14.62
68 Q7MXM8 DNA repair 38.3
69 Q7MTU1 Type II secretory pathway family 35.09
70 Q7MTB1 DNA repair 15.39
71 Q7MW65 DNA replication 23.28
72 Q7MUL4 Metal binding 49.9
73 Q7MVZ8 Metal binding 40.91
74 Q7MX05 ATP-binding cassette family 9.27
75 Q7MV50 Transporter 25.95

3.6 Homology modeling

The SWISS-MODEL approach was employed for carrying out homology modeling to construct the three-dimensional structure of the HP [33]. Uddin et al. constructed homology modeling for a protein (WP_003899216.1); however, the used model was different [52]. In this study, for a query Q7MXM8, the 3D structure of a known arginine deaminase (PDB I.D: 1ZBR. A) was adopted as a modular structure. The three-dimensional structure had with 97% identity, 100% query coverage, and 50% positives. The developed protein motif segment is represented in Figure 3 which was verified by VERIFY3D, PROCHECK, and ERRAT. The Ramachandran plot is depicted in Figure 4 and determined by PROCHECK revealed that 88.8% of the residues were found within the most favored region, while 10.9% were located in the additional allowed region, 0.3% were located in the generously permitted region, and 0% were found in the disallowed region. The ERRAT revealed an overall quality factor of 82.9% (Figure 5), whereas VERIFY3D approved the structure, and at least 97.35% of the amino acids score was greater than 0.2 in the 3D/1D profile (Figure 6). Furthermore, the underlying secondary structural features were forecasted by the PSIPRED package as described in Figure 7. The findings revealed that the initial β strand was located near the N-terminus of the structure and consisted of amino acid residues 13 to 19. Conversely, the first α helix was also found to be located near the N-terminus and contained amino acid residues 28 to 46.

Figure 3 
                  Developed 3D structure of query protein Q7MXM8.
Figure 3

Developed 3D structure of query protein Q7MXM8.

Figure 4 
                  Ramachandran plot of query protein Q7MXM8.
Figure 4

Ramachandran plot of query protein Q7MXM8.

Figure 5 
                  The resulting output of ERRAT shows the quality factor.
Figure 5

The resulting output of ERRAT shows the quality factor.

Figure 6 
                  The result output of VERIFY3D shows 97% residues greater than 0.2.
Figure 6

The result output of VERIFY3D shows 97% residues greater than 0.2.

Figure 7 
                  The graphical output from the PSIPRED program for the prediction of secondary structure of protein sequence Q7MXM8.
Figure 7

The graphical output from the PSIPRED program for the prediction of secondary structure of protein sequence Q7MXM8.

3.7 Identification of domain and motif

In this study, only one protein was identified by the KAAS server as a component of the essential metabolic pathways that are vital to the bacterial life cycle. The above-mentioned steps also indicated that the selected protein is unique and non-homologous to the human host; therefore, this protein can be considered as a potential drug target against the P. gingivalis strain. Additionally, a domain scan was also executed using SMART as described in section 2.12, which disclosed that the potential domain protein of interest (Q7MXM8) was peptidyl agmatine deiminase. The implementation of the ScanProsite tool distinguished the signature fits in the protein deposited as the query. In the output, no hit was observed in this study. The GenomeNet Motif Finder identified motifs against Pfam motif libraries [53] as peptidyl-arginine deiminase (pfam database accession, PF04371, peptidyl-arginine deaminase, https://www.ebi.ac.uk/interpro/entry/pfam/PF04371/) from position 7-336 with an e-value (4.9 × 10−111) are shown in Figure 8.

Figure 8 
                  Identification of full-length peptide motif of the identified target protein (arginine deiminase).
Figure 8

Identification of full-length peptide motif of the identified target protein (arginine deiminase).

4 Conclusions

A subtractive genomics methodology was utilized to the complete proteome of the P. gingivalis strain (ATCC BAA-308/W83) which shows resistance to several antibiotics. Sub-cellular localization prediction revealed that out of 75 HPs, cytoplasmic, outer membrane, inner membrane, extracellular, and periplasmic proteins had 50 (67%), 11 (15%), 9 (12%), 1 (5%), and 4 (1%) drug targets, respectively. Out of 75 protein sequences of the P. gingivalis strain, KAAS led to the qualification of only one HP (putative arginine deiminase) which was found to be involved in the arginine and proline metabolic pathway (protein sequence with Id Q7MXM8 with KAAS server Ids: KO01100 metabolic pathways, KO00330). Putative arginine deiminase was found as a part of an essential metabolic pathway of the bacterial life cycle. This study reports this HP as a prospective drug target for investigation. The suggested drug target can potentially be explored further through the application of structure-based methods to identify novel molecular entities as potential drug contenders against the drug targets. This study further demonstrates that the domain and motif in the proposed protein are needed for function and its blocking can inhibit the growth of P. gingivalis. This study offers valuable insights in discovering potential drug targets; however, wet laboratory experimental validation remains imperative to elucidate the precise interactions and efficacy of the target.


# Both authors equally contributed.


Acknowledgement

The authors would like to extend sincere appreciation to Dr. Haleema Masud of the Institute of Advanced Studies (IAS) at the University of Warwick, Coventry, UK, for her valuable contribution to language editing assistance during the revision stage.

  1. Funding information: The authors are grateful to the Deputyship for Research & Innovation, Ministry of Education (MoE) Saudi Arabia for supporting funds for this research work (Project No. 442-61). The authors would also like to extend their gratitude to the Deanship of Scientific Research (DSR), Taibah University for its supervision and kind support.

  2. Author contributions: Conceptualization, Z.A., and J.N.; methodology, W.A., A.A., and M.F.S.; validation of study, W.A., A.M.A., and A.A.; formal analysis, Z.A, M.L., A.M.A., A.A.A., and M.F.S.; data curation, Z.A., J.N., A.A.A., and W.A.; writing-original draft preparation, A.A.A., Z.A., and M.L.; writing-review and editing, A.M.A., M.L., A.A.A., and Z.A. Funding Acquisition, M.L., and Z.A; Supervision, Z.A., and M.L. All authors have read and agreed to the published version of the manuscript. *Waqar Ahmad (W.A.), Javed Nawab (J.N.), Abdul Majeed Alqurashi (A.M.A.), Muhammad Faisal Siddiqui (M.F.S.), Ayman Ahmad Alkraiem (A.A.A.), Ali Akbar (A.A.), Ziaur Rahman (Z.A.), and Muhammad Latif (M.L.).

  3. Conflict of interest: The authors declare that they have no conflicts of interest.

  4. Ethical approval: This study is not related to the involvement of either humans or animals.

  5. Data availability statement: All data generated or analyzed during this study are included in this published article and its supplementary information file.

References

[1] Ruan J. Bergey’s manual of systematic bacteriology (second edition) Volume 5 and the study of Actinomycetes systematic in China. Wei Sheng Wu Xue Bao. 2013;53(6):521–30. PMID: 24028053.Search in Google Scholar

[2] Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A. 2008;105(36):13532–7. 10.1073/pnas.0803852105.Search in Google Scholar PubMed PubMed Central

[3] Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. The cell biology of bone metabolism. J Clin Pathol. 2008;61(5):577–87. 10.1136/jcp.2007.048868.Search in Google Scholar PubMed

[4] Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6(12):727–30. 10.1038/nrrheum.2010.139.Search in Google Scholar PubMed

[5] Olsen I, Progulske-Fox A. Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. J Oral Microbiol. 2015;7:28788. 10.3402/jom.v7.28788.Search in Google Scholar PubMed PubMed Central

[6] Fukasawa A, Kurita-Ochiai T, Hashizume T, Kobayashi R, Akimoto Y, Yamamoto M. Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet. Immunopharmacol Immunotoxicol. 2012;34(3):470–6. 10.3109/08923973.2011.627866.Search in Google Scholar PubMed

[7] Hayashi C, Viereck J, Hua N, Phinikaridou A, Madrigal AG, Gibson FC 3rd, et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis. 2011;215(1):52–9. 10.1016/j.atherosclerosis.2010.12.009.Search in Google Scholar PubMed PubMed Central

[8] Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002;105(7):861–7. 10.1161/hc0702.104178.Search in Google Scholar PubMed

[9] Madan M, Amar S. Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS One. 2008;3(9):e3204. 10.1371/journal.pone.0003204.Search in Google Scholar PubMed PubMed Central

[10] Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, et al. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One. 2011;6(5):e20240. 10.1371/journal.pone.0020240.Search in Google Scholar PubMed PubMed Central

[11] Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J, et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol. 2005;25(7):1446–51. 10.1161/01.ATV.0000167525.69400.9c.Search in Google Scholar PubMed

[12] Rams TE, Sautter JD, van Winkelhoff AJ. Emergence of antibiotic-resistant Porphyromonas gingivalis in United States periodontitis patients. Antibiotics. 2023;12(11):1584. 10.3390/antibiotics1211158.Search in Google Scholar

[13] Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–20. 10.1016/s0140-6736(05)67728-8.Search in Google Scholar

[14] Tribble GD, Lamont GJ, Progulske-Fox A, Lamont RJ. Conjugal transfer of chromosomal DNA contributes to genetic variation in the oral pathogen Porphyromonas gingivalis. J Bacteriol. 2007;189(17):6382–8. 10.1128/jb.00460-07.Search in Google Scholar

[15] Kuleš J, Horvatić A, Guillemin N, Galan A, Mrljak V, Bhide M. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases. Mol Biosyst. 2016;12(9):2680–94. 10.1039/c6mb00268d.Search in Google Scholar PubMed

[16] Kumar Jaiswal A, Tiwari S, Jamal SB, Barh D, Azevedo V, Soares SC. An in silico identification of common putative vaccine candidates against Treponema pallidum: A reverse vaccinology and subtractive genomics based approach. Int J Mol Sci. 2017;18(2):402. 10.3390/ijms18020402.Search in Google Scholar PubMed PubMed Central

[17] Rizwan M, Naz A, Ahmad J, Naz K, Obaid A, Parveen T, et al. VacSol: A high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology. BMC Bioinforma. 2017;18(1):106. 10.1186/s12859-017-1540-0.Search in Google Scholar PubMed PubMed Central

[18] Chen T, Siddiqui H, Olsen I. In silico Comparison of 19 Porphyromonas gingivalis strains in genomics, phylogenetics, phylogenomics and functional genomics. Front Cell Infect Microbiol. 2017;7:28. 10.3389/fcimb.2017.00028.Search in Google Scholar PubMed PubMed Central

[19] Sayers EW, Beck J, Bolton EE, Bourexis D, Brister JR, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2021;49(D1):D10–d7. 10.1093/nar/gkaa892.Search in Google Scholar PubMed PubMed Central

[20] Magrane M. UniProt Knowledgebase: A hub of integrated protein data. Database (Oxford). 2011;2011:bar009. 10.1093/database/bar009.Search in Google Scholar PubMed PubMed Central

[21] Camon E, Magrane M, Barrell D, Lee V, Dimmer E, Maslen J, et al. The Gene Ontology Annotation (GOA) database: Sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 2004;32(Database issue):D262–6. 10.1093/nar/gkh021.Search in Google Scholar PubMed PubMed Central

[22] Li W, Godzik A. Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006;22(13):1658–9. 10.1093/bioinformatics/btl158.Search in Google Scholar PubMed

[23] Naveed M, Tehreem S, Mubeen S, Nadeem F, Zafar F, Irshad M. In-silico analysis of non-synonymous-SNPs of STEAP2: To provoke the progression of prostate cancer. 2016;11(1):402–16. 10.1515/biol-2016-0054.Search in Google Scholar

[24] Zhang R, Ou HY, Zhang CT. DEG: A database of essential genes. Nucleic Acids Res. 2004;32(Database issue):D271–2. 10.1093/nar/gkh024.Search in Google Scholar PubMed PubMed Central

[25] Yu CS, Lin CJ, Hwang JK. Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci. 2004;13(5):1402–6. 10.1110/ps.03479604.Search in Google Scholar PubMed PubMed Central

[26] Bakheet TM, Doig AJ. Properties and identification of antibiotic drug targets. BMC Bioinforma. 2010;11:195. 10.1186/1471-2105-11-195.Search in Google Scholar PubMed PubMed Central

[27] Garmory HS, Titball RW. ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun. 2004;72(12):6757–63. 10.1128/iai.72.12.6757-6763.2004.Search in Google Scholar PubMed PubMed Central

[28] Cai CZ, Han LY, Ji ZL, Chen X, Chen YZ. SVM-Prot: Web-based support vector machine software for functional classification of a protein from its primary sequence. Nucleic Acids Res. 2003;31(13):3692–7. 10.1093/nar/gkg600.Search in Google Scholar PubMed PubMed Central

[29] Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32(Database issue):D277–80. 10.1093/nar/gkh063.Search in Google Scholar PubMed PubMed Central

[30] Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M. KAAS: An automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 2007;35(Web Server issue):W182–5. 10.1093/nar/gkm321.Search in Google Scholar PubMed PubMed Central

[31] Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6 No 1):899–907. 10.1107/s0907444902003451.Search in Google Scholar PubMed

[32] Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S. Protein Data Bank (PDB): The single global macromolecular structure archive. Methods Mol Biol. 2017;1607:627–41. 10.1007/978-1-4939-7000-1_26.Search in Google Scholar PubMed PubMed Central

[33] Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–w303. 10.1093/nar/gky427.Search in Google Scholar PubMed PubMed Central

[34] Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26(2):283–91. 10.1107/S0021889892009944.Search in Google Scholar

[35] Eisenberg D, Lüthy R, Bowie JU. VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods Enzymol. 1997;277:396–404. 10.1016/s0076-6879(97)77022-8.Search in Google Scholar PubMed

[36] Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511–9. 10.1002/pro.5560020916.Search in Google Scholar PubMed PubMed Central

[37] Goodacre NF, Gerloff DL, Uetz P. Protein domains of unknown function are essential in bacteria. mBio. 2013;5(1):e00744–13. 10.1128/mBio.00744-13.Search in Google Scholar PubMed PubMed Central

[38] Desler C, Suravajhala P, Sanderhoff M, Rasmussen M, Rasmussen LJ. In Silico screening for functional candidates amongst hypothetical proteins. BMC Bioinforma. 2009;10:289. 10.1186/1471-2105-10-289.Search in Google Scholar PubMed PubMed Central

[39] Schultz J, Milpetz F, Bork P, Ponting CP. SMART, a simple modular architecture research tool: identification of signaling domains. Proc Natl Acad Sci U S A. 1998;95(11):5857–64. 10.1073/pnas.95.11.5857.Search in Google Scholar PubMed PubMed Central

[40] de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, et al. ScanProsite: Detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res. 2006;34(Web Server issue):W362–5. 10.1093/nar/gkl124.Search in Google Scholar PubMed PubMed Central

[41] Hogue CWV, Ohkawa H, Bryant SH. A dynamic look at structures: WWW-entrez and the molecular modeling database. Trends Biochem Sci. 1996;21(6):226–9. 10.1016/S0968-0004(96)80021-1.Search in Google Scholar

[42] Barh D, Tiwari S, Jain N, Ali A, Santos AR, Misra AN, et al. In silico subtractive genomics for target identification in human bacterial pathogens. Drug Dev Res. 2011;72(2):162–77. 10.1002/ddr.20413.Search in Google Scholar

[43] Chhabra G, Sharma P, Anant A, Deshmukh S, Kaushik H, Gopal K, et al. Identification and modeling of a drug target for Clostridium perfringens SM101. Bioinformation. 2010;4(7):278–89. 10.6026/97320630004278.Search in Google Scholar PubMed PubMed Central

[44] Dutta A, Singh SK, Ghosh P, Mukherjee R, Mitter S, Bandyopadhyay D. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. Silico Biol. 2006;6(1–2):43–7.Search in Google Scholar

[45] Sarangi AN, Aggarwal R, Rahman Q, Trivedi N. Subtractive genomics approach for in silico identification and characterization of novel drug targets in Neisseria Meningitides Serogroup B. J Computer Sci Syst Biol. 2009;2(5):255–8. 10.4172/jcsb.1000038.Search in Google Scholar

[46] Fu L, Niu B, Zhu Z, Wu S, Li W. CD-HIT: Accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012;28(23):3150–2. 10.1093/bioinformatics/bts565.Search in Google Scholar PubMed PubMed Central

[47] Gao F, Luo H, Zhang CT, Zhang R. Gene essentiality analysis based on DEG 10, an updated database of essential genes. Methods Mol Biol. 2015;1279:219–33. 10.1007/978-1-4939-2398-4_14.Search in Google Scholar PubMed

[48] Zhou Y, Yang W, Kirberger M, Lee H-W, Ayalasomayajula G, Yang JJ. Prediction of EF-hand calcium-binding proteins and analysis of bacterial EF-hand proteins. Proteins: Struct Funct Bioinforma. 2006;65(3):643–55. 10.1002/prot.21139.Search in Google Scholar PubMed

[49] Das S, Sillitoe I, Lee D, Lees JG, Dawson NL, Ward J, et al. CATH FunFHMMer web server: Protein functional annotations using functional family assignments. Nucleic Acids Res. 2015;43(W1):W148–53. 10.1093/nar/gkv488.Search in Google Scholar PubMed PubMed Central

[50] Uddin R, Siraj B, Rashid M, Khan A, Ahsan Halim S, Al-Harrasi A. Genome subtraction and comparison for the identification of novel drug targets against Mycobacterium avium subsp. hominissuis. Pathogens. 2020;9(5). 10.3390/pathogens9050368.Search in Google Scholar PubMed PubMed Central

[51] Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–d61. 10.1093/nar/gkw1092.Search in Google Scholar PubMed PubMed Central

[52] Uddin R, Siddiqui QN, Azam SS, Saima B, Wadood A. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach. Eur J Pharm Sci. 2018;114:13–23. 10.1016/j.ejps.2017.11.014.Search in Google Scholar PubMed

[53] Bateman A, Birney E, Cerruti L, Durbin R, Etwiller L, Eddy SR, et al. The Pfam protein families database. Nucleic Acids Res. 2002;30(1):276–80. 10.1093/nar/30.1.276.Search in Google Scholar PubMed PubMed Central

Received: 2024-02-14
Revised: 2024-04-16
Accepted: 2024-04-21
Published Online: 2024-06-13

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Regular Articles
  2. Porous silicon nanostructures: Synthesis, characterization, and their antifungal activity
  3. Biochar from de-oiled Chlorella vulgaris and its adsorption on antibiotics
  4. Phytochemicals profiling, in vitro and in vivo antidiabetic activity, and in silico studies on Ajuga iva (L.) Schreb.: A comprehensive approach
  5. Synthesis, characterization, in silico and in vitro studies of novel glycoconjugates as potential antibacterial, antifungal, and antileishmanial agents
  6. Sonochemical synthesis of gold nanoparticles mediated by potato starch: Its performance in the treatment of esophageal cancer
  7. Computational study of ADME-Tox prediction of selected phytochemicals from Punica granatum peels
  8. Phytochemical analysis, in vitro antioxidant and antifungal activities of extracts and essential oil derived from Artemisia herba-alba Asso
  9. Two triazole-based coordination polymers: Synthesis and crystal structure characterization
  10. Phytochemical and physicochemical studies of different apple varieties grown in Morocco
  11. Synthesis of multi-template molecularly imprinted polymers (MT-MIPs) for isolating ethyl para-methoxycinnamate and ethyl cinnamate from Kaempferia galanga L., extract with methacrylic acid as functional monomer
  12. Nutraceutical potential of Mesembryanthemum forsskaolii Hochst. ex Bioss.: Insights into its nutritional composition, phytochemical contents, and antioxidant activity
  13. Evaluation of influence of Butea monosperma floral extract on inflammatory biomarkers
  14. Cannabis sativa L. essential oil: Chemical composition, anti-oxidant, anti-microbial properties, and acute toxicity: In vitro, in vivo, and in silico study
  15. The effect of gamma radiation on 5-hydroxymethylfurfural conversion in water and dimethyl sulfoxide
  16. Hollow mushroom nanomaterials for potentiometric sensing of Pb2+ ions in water via the intercalation of iodide ions into the polypyrrole matrix
  17. Determination of essential oil and chemical composition of St. John’s Wort
  18. Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus
  19. Anti-parasitic activity and computational studies on a novel labdane diterpene from the roots of Vachellia nilotica
  20. Microbial dynamics and dehydrogenase activity in tomato (Lycopersicon esculentum Mill.) rhizospheres: Impacts on growth and soil health across different soil types
  21. Correlation between in vitro anti-urease activity and in silico molecular modeling approach of novel imidazopyridine–oxadiazole hybrids derivatives
  22. Spatial mapping of indoor air quality in a light metro system using the geographic information system method
  23. Iron indices and hemogram in renal anemia and the improvement with Tribulus terrestris green-formulated silver nanoparticles applied on rat model
  24. Integrated track of nano-informatics coupling with the enrichment concept in developing a novel nanoparticle targeting ERK protein in Naegleria fowleri
  25. Cytotoxic and phytochemical screening of Solanum lycopersicum–Daucus carota hydro-ethanolic extract and in silico evaluation of its lycopene content as anticancer agent
  26. Protective activities of silver nanoparticles containing Panax japonicus on apoptotic, inflammatory, and oxidative alterations in isoproterenol-induced cardiotoxicity
  27. pH-based colorimetric detection of monofunctional aldehydes in liquid and gas phases
  28. Investigating the effect of resveratrol on apoptosis and regulation of gene expression of Caco-2 cells: Unravelling potential implications for colorectal cancer treatment
  29. Metformin inhibits knee osteoarthritis induced by type 2 diabetes mellitus in rats: S100A8/9 and S100A12 as players and therapeutic targets
  30. Effect of silver nanoparticles formulated by Silybum marianum on menopausal urinary incontinence in ovariectomized rats
  31. Synthesis of new analogs of N-substituted(benzoylamino)-1,2,3,6-tetrahydropyridines
  32. Response of yield and quality of Japonica rice to different gradients of moisture deficit at grain-filling stage in cold regions
  33. Preparation of an inclusion complex of nickel-based β-cyclodextrin: Characterization and accelerating the osteoarthritis articular cartilage repair
  34. Empagliflozin-loaded nanomicelles responsive to reactive oxygen species for renal ischemia/reperfusion injury protection
  35. Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles
  36. Assessment of potentially toxic elements and health risks of agricultural soil in Southwest Riyadh, Saudi Arabia
  37. Theoretical investigation of hydrogen-rich fuel production through ammonia decomposition
  38. Biosynthesis and screening of cobalt nanoparticles using citrus species for antimicrobial activity
  39. Investigating the interplay of genetic variations, MCP-1 polymorphism, and docking with phytochemical inhibitors for combatting dengue virus pathogenicity through in silico analysis
  40. Ultrasound induced biosynthesis of silver nanoparticles embedded into chitosan polymers: Investigation of its anti-cutaneous squamous cell carcinoma effects
  41. Copper oxide nanoparticles-mediated Heliotropium bacciferum leaf extract: Antifungal activity and molecular docking assays against strawberry pathogens
  42. Sprouted wheat flour for improving physical, chemical, rheological, microbial load, and quality properties of fino bread
  43. Comparative toxicity assessment of fisetin-aided artificial intelligence-assisted drug design targeting epibulbar dermoid through phytochemicals
  44. Acute toxicity and anti-inflammatory activity of bis-thiourea derivatives
  45. Anti-diabetic activity-guided isolation of α-amylase and α-glucosidase inhibitory terpenes from Capsella bursa-pastoris Linn.
  46. GC–MS analysis of Lactobacillus plantarum YW11 metabolites and its computational analysis on familial pulmonary fibrosis hub genes
  47. Green formulation of copper nanoparticles by Pistacia khinjuk leaf aqueous extract: Introducing a novel chemotherapeutic drug for the treatment of prostate cancer
  48. Improved photocatalytic properties of WO3 nanoparticles for Malachite green dye degradation under visible light irradiation: An effect of La doping
  49. One-pot synthesis of a network of Mn2O3–MnO2–poly(m-methylaniline) composite nanorods on a polypyrrole film presents a promising and efficient optoelectronic and solar cell device
  50. Groundwater quality and health risk assessment of nitrate and fluoride in Al Qaseem area, Saudi Arabia
  51. A comparative study of the antifungal efficacy and phytochemical composition of date palm leaflet extracts
  52. Processing of alcohol pomelo beverage (Citrus grandis (L.) Osbeck) using saccharomyces yeast: Optimization, physicochemical quality, and sensory characteristics
  53. Specialized compounds of four Cameroonian spices: Isolation, characterization, and in silico evaluation as prospective SARS-CoV-2 inhibitors
  54. Identification of a novel drug target in Porphyromonas gingivalis by a computational genome analysis approach
  55. Physico-chemical properties and durability of a fly-ash-based geopolymer
  56. FMS-like tyrosine kinase 3 inhibitory potentials of some phytochemicals from anti-leukemic plants using computational chemical methodologies
  57. Wild Thymus zygis L. ssp. gracilis and Eucalyptus camaldulensis Dehnh.: Chemical composition, antioxidant and antibacterial activities of essential oils
  58. 3D-QSAR, molecular docking, ADMET, simulation dynamic, and retrosynthesis studies on new styrylquinolines derivatives against breast cancer
  59. Deciphering the influenza neuraminidase inhibitory potential of naturally occurring biflavonoids: An in silico approach
  60. Determination of heavy elements in agricultural regions, Saudi Arabia
  61. Synthesis and characterization of antioxidant-enriched Moringa oil-based edible oleogel
  62. Ameliorative effects of thistle and thyme honeys on cyclophosphamide-induced toxicity in mice
  63. Study of phytochemical compound and antipyretic activity of Chenopodium ambrosioides L. fractions
  64. Investigating the adsorption mechanism of zinc chloride-modified porous carbon for sulfadiazine removal from water
  65. Performance repair of building materials using alumina and silica composite nanomaterials with electrodynamic properties
  66. Effects of nanoparticles on the activity and resistance genes of anaerobic digestion enzymes in livestock and poultry manure containing the antibiotic tetracycline
  67. Effect of copper nanoparticles green-synthesized using Ocimum basilicum against Pseudomonas aeruginosa in mice lung infection model
  68. Cardioprotective effects of nanoparticles green formulated by Spinacia oleracea extract on isoproterenol-induced myocardial infarction in mice by the determination of PPAR-γ/NF-κB pathway
  69. Anti-OTC antibody-conjugated fluorescent magnetic/silica and fluorescent hybrid silica nanoparticles for oxytetracycline detection
  70. Curcumin conjugated zinc nanoparticles for the treatment of myocardial infarction
  71. Identification and in silico screening of natural phloroglucinols as potential PI3Kα inhibitors: A computational approach for drug discovery
  72. Exploring the phytochemical profile and antioxidant evaluation: Molecular docking and ADMET analysis of main compounds from three Solanum species in Saudi Arabia
  73. Unveiling the molecular composition and biological properties of essential oil derived from the leaves of wild Mentha aquatica L.: A comprehensive in vitro and in silico exploration
  74. Analysis of bioactive compounds present in Boerhavia elegans seeds by GC-MS
  75. Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases
  76. LncRNA MIR17HG alleviates heart failure via targeting MIR17HG/miR-153-3p/SIRT1 axis in in vitro model
  77. Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
  78. Biosynthesis of Ag/Cu nanocomposite mediated by Curcuma longa: Evaluation of its antibacterial properties against oral pathogens
  79. Development of AMBER-compliant transferable force field parameters for polytetrafluoroethylene
  80. Treatment of gestational diabetes by Acroptilon repens leaf aqueous extract green-formulated iron nanoparticles in rats
  81. Development and characterization of new ecological adsorbents based on cardoon wastes: Application to brilliant green adsorption
  82. A fast, sensitive, greener, and stability-indicating HPLC method for the standardization and quantitative determination of chlorhexidine acetate in commercial products
  83. Assessment of Se, As, Cd, Cr, Hg, and Pb content status in Ankang tea plantations of China
  84. Effect of transition metal chloride (ZnCl2) on low-temperature pyrolysis of high ash bituminous coal
  85. Evaluating polyphenol and ascorbic acid contents, tannin removal ability, and physical properties during hydrolysis and convective hot-air drying of cashew apple powder
  86. Development and characterization of functional low-fat frozen dairy dessert enhanced with dried lemongrass powder
  87. Scrutinizing the effect of additive and synergistic antibiotics against carbapenem-resistant Pseudomonas aeruginosa
  88. Preparation, characterization, and determination of the therapeutic effects of copper nanoparticles green-formulated by Pistacia atlantica in diabetes-induced cardiac dysfunction in rat
  89. Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches
  90. Anti-melanoma cancer activity and chemical profile of the essential oil of Seseli yunnanense Franch
  91. Molecular docking analysis of subtilisin-like alkaline serine protease (SLASP) and laccase with natural biopolymers
  92. Overcoming methicillin resistance by methicillin-resistant Staphylococcus aureus: Computational evaluation of napthyridine and oxadiazoles compounds for potential dual inhibition of PBP-2a and FemA proteins
  93. Exploring novel antitubercular agents: Innovative design of 2,3-diaryl-quinoxalines targeting DprE1 for effective tuberculosis treatment
  94. Drimia maritima flowers as a source of biologically potent components: Optimization of bioactive compound extractions, isolation, UPLC–ESI–MS/MS, and pharmacological properties
  95. Estimating molecular properties, drug-likeness, cardiotoxic risk, liability profile, and molecular docking study to characterize binding process of key phyto-compounds against serotonin 5-HT2A receptor
  96. Fabrication of β-cyclodextrin-based microgels for enhancing solubility of Terbinafine: An in-vitro and in-vivo toxicological evaluation
  97. Phyto-mediated synthesis of ZnO nanoparticles and their sunlight-driven photocatalytic degradation of cationic and anionic dyes
  98. Monosodium glutamate induces hypothalamic–pituitary–adrenal axis hyperactivation, glucocorticoid receptors down-regulation, and systemic inflammatory response in young male rats: Impact on miR-155 and miR-218
  99. Quality control analyses of selected honey samples from Serbia based on their mineral and flavonoid profiles, and the invertase activity
  100. Eco-friendly synthesis of silver nanoparticles using Phyllanthus niruri leaf extract: Assessment of antimicrobial activity, effectiveness on tropical neglected mosquito vector control, and biocompatibility using a fibroblast cell line model
  101. Green synthesis of silver nanoparticles containing Cichorium intybus to treat the sepsis-induced DNA damage in the liver of Wistar albino rats
  102. Quality changes of durian pulp (Durio ziberhinus Murr.) in cold storage
  103. Study on recrystallization process of nitroguanidine by directly adding cold water to control temperature
  104. Determination of heavy metals and health risk assessment in drinking water in Bukayriyah City, Saudi Arabia
  105. Larvicidal properties of essential oils of three Artemisia species against the chemically insecticide-resistant Nile fever vector Culex pipiens (L.) (Diptera: Culicidae): In vitro and in silico studies
  106. Design, synthesis, characterization, and theoretical calculations, along with in silico and in vitro antimicrobial proprieties of new isoxazole-amide conjugates
  107. The impact of drying and extraction methods on total lipid, fatty acid profile, and cytotoxicity of Tenebrio molitor larvae
  108. A zinc oxide–tin oxide–nerolidol hybrid nanomaterial: Efficacy against esophageal squamous cell carcinoma
  109. Research on technological process for production of muskmelon juice (Cucumis melo L.)
  110. Physicochemical components, antioxidant activity, and predictive models for quality of soursop tea (Annona muricata L.) during heat pump drying
  111. Characterization and application of Fe1−xCoxFe2O4 nanoparticles in Direct Red 79 adsorption
  112. Torilis arvensis ethanolic extract: Phytochemical analysis, antifungal efficacy, and cytotoxicity properties
  113. Magnetite–poly-1H pyrrole dendritic nanocomposite seeded on poly-1H pyrrole: A promising photocathode for green hydrogen generation from sanitation water without using external sacrificing agent
  114. HPLC and GC–MS analyses of phytochemical compounds in Haloxylon salicornicum extract: Antibacterial and antifungal activity assessment of phytopathogens
  115. Efficient and stable to coking catalysts of ethanol steam reforming comprised of Ni + Ru loaded on MgAl2O4 + LnFe0.7Ni0.3O3 (Ln = La, Pr) nanocomposites prepared via cost-effective procedure with Pluronic P123 copolymer
  116. Nitrogen and boron co-doped carbon dots probe for selectively detecting Hg2+ in water samples and the detection mechanism
  117. Heavy metals in road dust from typical old industrial areas of Wuhan: Seasonal distribution and bioaccessibility-based health risk assessment
  118. Phytochemical profiling and bioactivity evaluation of CBD- and THC-enriched Cannabis sativa extracts: In vitro and in silico investigation of antioxidant and anti-inflammatory effects
  119. Investigating dye adsorption: The role of surface-modified montmorillonite nanoclay in kinetics, isotherms, and thermodynamics
  120. Antimicrobial activity, induction of ROS generation in HepG2 liver cancer cells, and chemical composition of Pterospermum heterophyllum
  121. Study on the performance of nanoparticle-modified PVDF membrane in delaying membrane aging
  122. Impact of cholesterol in encapsulated vitamin E acetate within cocoliposomes
  123. Review Articles
  124. Structural aspects of Pt(η3-X1N1X2)(PL) (X1,2 = O, C, or Se) and Pt(η3-N1N2X1)(PL) (X1 = C, S, or Se) derivatives
  125. Biosurfactants in biocorrosion and corrosion mitigation of metals: An overview
  126. Stimulus-responsive MOF–hydrogel composites: Classification, preparation, characterization, and their advancement in medical treatments
  127. Electrochemical dissolution of titanium under alternating current polarization to obtain its dioxide
  128. Special Issue on Recent Trends in Green Chemistry
  129. Phytochemical screening and antioxidant activity of Vitex agnus-castus L.
  130. Phytochemical study, antioxidant activity, and dermoprotective activity of Chenopodium ambrosioides (L.)
  131. Exploitation of mangliculous marine fungi, Amarenographium solium, for the green synthesis of silver nanoparticles and their activity against multiple drug-resistant bacteria
  132. Study of the phytotoxicity of margines on Pistia stratiotes L.
  133. Special Issue on Advanced Nanomaterials for Energy, Environmental and Biological Applications - Part III
  134. Impact of biogenic zinc oxide nanoparticles on growth, development, and antioxidant system of high protein content crop (Lablab purpureus L.) sweet
  135. Green synthesis, characterization, and application of iron and molybdenum nanoparticles and their composites for enhancing the growth of Solanum lycopersicum
  136. Green synthesis of silver nanoparticles from Olea europaea L. extracted polysaccharides, characterization, and its assessment as an antimicrobial agent against multiple pathogenic microbes
  137. Photocatalytic treatment of organic dyes using metal oxides and nanocomposites: A quantitative study
  138. Antifungal, antioxidant, and photocatalytic activities of greenly synthesized iron oxide nanoparticles
  139. Special Issue on Phytochemical and Pharmacological Scrutinization of Medicinal Plants
  140. Hepatoprotective effects of safranal on acetaminophen-induced hepatotoxicity in rats
  141. Chemical composition and biological properties of Thymus capitatus plants from Algerian high plains: A comparative and analytical study
  142. Chemical composition and bioactivities of the methanol root extracts of Saussurea costus
  143. In vivo protective effects of vitamin C against cyto-genotoxicity induced by Dysphania ambrosioides aqueous extract
  144. Insights about the deleterious impact of a carbamate pesticide on some metabolic immune and antioxidant functions and a focus on the protective ability of a Saharan shrub and its anti-edematous property
  145. A comprehensive review uncovering the anticancerous potential of genkwanin (plant-derived compound) in several human carcinomas
  146. A study to investigate the anticancer potential of carvacrol via targeting Notch signaling in breast cancer
  147. Assessment of anti-diabetic properties of Ziziphus oenopolia (L.) wild edible fruit extract: In vitro and in silico investigations through molecular docking analysis
  148. Optimization of polyphenol extraction, phenolic profile by LC-ESI-MS/MS, antioxidant, anti-enzymatic, and cytotoxic activities of Physalis acutifolia
  149. Phytochemical screening, antioxidant properties, and photo-protective activities of Salvia balansae de Noé ex Coss
  150. Antihyperglycemic, antiglycation, anti-hypercholesteremic, and toxicity evaluation with gas chromatography mass spectrometry profiling for Aloe armatissima leaves
  151. Phyto-fabrication and characterization of gold nanoparticles by using Timur (Zanthoxylum armatum DC) and their effect on wound healing
  152. Does Erodium trifolium (Cav.) Guitt exhibit medicinal properties? Response elements from phytochemical profiling, enzyme-inhibiting, and antioxidant and antimicrobial activities
  153. Integrative in silico evaluation of the antiviral potential of terpenoids and its metal complexes derived from Homalomena aromatica based on main protease of SARS-CoV-2
  154. 6-Methoxyflavone improves anxiety, depression, and memory by increasing monoamines in mice brain: HPLC analysis and in silico studies
  155. Simultaneous extraction and quantification of hydrophilic and lipophilic antioxidants in Solanum lycopersicum L. varieties marketed in Saudi Arabia
  156. Biological evaluation of CH3OH and C2H5OH of Berberis vulgaris for in vivo antileishmanial potential against Leishmania tropica in murine models
Downloaded on 6.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/chem-2024-0037/html
Scroll to top button